Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Juan A. Gómez-Fregoso"'
Autor:
Luz Alcantar-Vallin, Jose J. Zaragoza, Bladimir Díaz-Villavicencio, Karla Hernandez-Morales, Jahir R. Camacho-Guerrero, Miguel A. Perez-Venegas, Edgar J. Carmona-Morales, Alexa N. Oseguera-Gonzalez, Cesar Murguia-Soto, Gael Chávez-Alonso, José M. Arredondo-Dubois, Carlos E. Orozco-Chan, Juan A. Gómez-Fregoso, Francisco G. Rodríguez-García, Guillermo Navarro-Blackaller, Ramón Medina-González, Alejandro Martínez Gallardo-González, Gabriela J. Abundis-Mora, Olynka Vega-Vega, Guillermo García-García, Jonathan S. Chávez-Iñiguez
Publikováno v:
Frontiers in Pharmacology, Vol 15 (2024)
BackgroundThe association between the administration of sodium–glucose cotransporter 2 inhibitors (SGLT2is) during acute kidney injury (AKI) and the incidence of major adverse kidney events (MAKEs) is not known.MethodsThis retrospective cohort stud
Externí odkaz:
https://doaj.org/article/77177721c5b247e9b43e04ecbba4a728
Decrease in platelet count in patients with AKI and its association with major adverse kidney events
Autor:
Ramón Medina-González, Jose J. Zaragoza, Eduardo M. Hernández-Barajas, Juarez Correa-de Leon, Rolando Claure-Del Granado, Armando Vazquez-Rangel, Liliana M. Pineda-Segura, Martha K. Franco-Garcia, Gael Chávez-Alonso, Juan A. Gómez-Fregoso, Francisco G. Rodríguez-García, Guillermo Navarro-Blackaller, Luz Alcantar-Vallin, Alejandro Martínez Gallardo-González, Gabriela J. Abundis-Mora, Guillermo García-García, Jonathan S. Chávez-Iñiguez
Publikováno v:
Renal Failure, Vol 46, Iss 1 (2024)
Introduction A reduction in platelet count in critically ill patients is a marker of severity of the clinical condition. However, whether this association holds true in acute kidney injury (AKI) is unknown. We analyzed the association between platele
Externí odkaz:
https://doaj.org/article/727b965aa94f45f387bb77748d6e0091
Autor:
Jonathan S. Chávez-Iñiguez, Jose J. Zaragoza, Jahir R. Camacho-Guerrero, Vanessa Villavicencio-Cerón, Rafael Valdez-Ortiz, Ana E. Huerta-Orozco, Gael Chávez-Alonso, Ana E. Oliva-Martinez, Bladimir Díaz-Villavicencio, Clementina E. Calderón-García, Jose D. González-Barajas, Manuel Arizaga-Nápoles, Frida M. De La Vega-Méndez, Juan A. Gómez-Fregoso, Francisco G. Rodríguez-García, Guillermo Navarro-Blackaller, Ramón Medina-González, Luz Alcantar-Vallin, Guillermo García-García
Publikováno v:
Kidney & Blood Pressure Research, Pp 1-1 (2023)
Introduction: In patients with chronic kidney disease stages 4 and 5 (CKD stages 4–5) without dialysis and arterial hypertension, it is unknown if the values of systolic blood pressure (SBP) considered in control (120 mm Hg), the uncontrolled group
Externí odkaz:
https://doaj.org/article/10613f1dfaaf40059e778e6bb77a5166
Autor:
Guillermo Garcia-Garcia, Guillermo Navarro Blackaller, Jonathan S Chávez-Iñiguez, Juan Alberto Gómez Fregoso, Pablo Maggiani Aguilera, Elsa Edith Carreón-Bautista, Francisco Javier González-Torres, Francisco Romo Rosales, Jorge Isaac Michel Gonzalez, José Roberto Barrientos Avalos, Miroslava Villareal-Contreras, Torres Mayorga José Antonio
Publikováno v:
Kidney International Reports
Introduction Thyroid hormones can directly affect kidney function; elevated levels of thyroid-stimulating hormone (TSH) and chronic kidney disease (CKD) are associated with proteinuria, decreased estimated glomerular filtration rate (eGFR), and progr